Schonfeld Strategic Advisors LLC Silverback Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
N/A
27,139 New
27,139 $0
Q4 2023

Feb 14, 2024
BUY
N/A
16,500 New
16,500 $0
Q3 2022

Nov 14, 2022
SELL
$3.91 - $5.52 $34,408 - $48,575
-8,800 Reduced 43.14%
11,600 $62,000
Q2 2022

Aug 15, 2022
SELL
$2.9 - $4.44 $23,490 - $35,964
-8,100 Reduced 28.42%
20,400 $86,000
Q1 2022

May 16, 2022
BUY
$3.51 - $6.74 $100,035 - $192,090
28,500 New
28,500 $100,000

Others Institutions Holding SBTX

# of Institutions
163
Shares Held
62.7M
Call Options Held
872K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email